These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38793802)

  • 1. Vaccine Acceptance in Patients with Inflammatory Bowel Disease: Lessons Learned from the COVID-19 Pandemic.
    Mastrangeli G; Vernia F; Necozione S; Muselli M; Frassino S; Cesaro N; Latella G; Fabiani L
    Vaccines (Basel); 2024 May; 12(5):. PubMed ID: 38793802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in Coronavirus disease - 19 vaccination related side effects in patients with ulcerative colitis and Crohn's disease in Japan.
    Miyazaki H; Watanabe D; Ito Y; Ikeda S; Okamoto N; Tokunaga E; Ku Y; Ooi M; Hoshi N; Kodama Y
    Indian J Gastroenterol; 2023 Oct; 42(5):701-707. PubMed ID: 37505394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 Vaccine Hesitancy among Patients with Inflammatory Bowel Disease Receiving Biologic Therapies in Kuwait: A Cross-Sectional Study.
    Shehab M; Zurba Y; Al Abdulsalam A; Alfadhli A; Elouali S
    Vaccines (Basel); 2021 Dec; 10(1):. PubMed ID: 35062716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of anti-SARS-CoV-2 BNT162b2 mRNA vaccination on thrombin generation in children with inflammatory bowel disease.
    Stercel V; Lóczi L; Kadenczki O; Nemes É; Nagy B; Hodossy-Takács R; Szabó AÁ; Fagyas M; Kappelmayer J; Szabó T; Bagoly Z
    Front Immunol; 2023; 14():1257072. PubMed ID: 37965328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study.
    Alexander JL; Liu Z; Muñoz Sandoval D; Reynolds C; Ibraheim H; Anandabaskaran S; Saifuddin A; Castro Seoane R; Anand N; Nice R; Bewshea C; D'Mello A; Constable L; Jones GR; Balarajah S; Fiorentino F; Sebastian S; Irving PM; Hicks LC; Williams HRT; Kent AJ; Linger R; Parkes M; Kok K; Patel KV; Teare JP; Altmann DM; Goodhand JR; Hart AL; Lees CW; Boyton RJ; Kennedy NA; Ahmad T; Powell N;
    Lancet Gastroenterol Hepatol; 2022 Nov; 7(11):1005-1015. PubMed ID: 36088954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID.
    Weaver KN; Zhang X; Dai X; Watkins R; Adler J; Dubinsky MC; Kastl A; Bousvaros A; Strople JA; Cross RK; Higgins PDR; Ungaro RC; Bewtra M; Bellaguarda E; Farraye FA; Boccieri ME; Firestine A; Kappelman MD; Long MD
    Inflamm Bowel Dis; 2022 Oct; 28(10):1497-1505. PubMed ID: 34871388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Vaccination Against COVID-19 Associated With Inflammatory Bowel Disease Flare? Self-Controlled Case Series Analysis Using the UK CPRD.
    Card TR; Nakafero G; Grainge MJ; Mallen CD; Van-Tam JSN; Williams HC; Abhishek A
    Am J Gastroenterol; 2023 Aug; 118(8):1388-1394. PubMed ID: 36826512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody Response to SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease: Results of a Single-Center Cohort Study in a Tertiary Hospital in Germany.
    Classen JM; Muzalyova A; Nagl S; Fleischmann C; Ebigbo A; Römmele C; Messmann H; Schnoy E
    Dig Dis; 2022; 40(6):719-727. PubMed ID: 34915480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misconceptions Drive COVID-19 Vaccine Hesistancy in Individuals with Inflammatory Bowel Disease.
    Zhang E; Gupta A; Al-Ani A; Macrae FA; Leong RW; Christensen B
    Can J Gastroenterol Hepatol; 2022; 2022():4527844. PubMed ID: 36124090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 vaccine acceptance among gastroenterologists and inflammatory bowel disease patients: VACUNEII project.
    Ferreiro-Iglesias R; Hernández-Camba A; Serrano Labajos R; Rodríguez-Lago I; Zabana Y; Barreiro-de Acosta M;
    Gastroenterol Hepatol; 2022 Dec; 45(10):737-741. PubMed ID: 34453969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 vaccination rate and willingness of an additional dose among inflammatory bowel disease patients receiving biologic therapy: Fearless and with desire.
    Ramos L; Carrillo-Palau M; Alonso-Abreu I; Reygosa C; Hernández-Alvarez N; Amaral C; Hernández A; Benítez-Zafra F; Pérez-González F; Quintana-Díaz H; Hernandez-Guerra M
    Gastroenterol Hepatol; 2023 Apr; 46(4):255-260. PubMed ID: 35609791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes towards Vaccinations in a National Italian Cohort of Patients with Inflammatory Bowel Disease.
    Costantino A; Michelon M; Noviello D; Macaluso FS; Leone S; Bonaccorso N; Costantino C; Vecchi M; Caprioli F;
    Vaccines (Basel); 2023 Oct; 11(10):. PubMed ID: 37896993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients.
    Alexander JL; Mullish BH; Danckert NP; Liu Z; Olbei ML; Saifuddin A; Torkizadeh M; Ibraheim H; Blanco JM; Roberts LA; Bewshea CM; Nice R; Lin S; Prabhudev H; Sands C; Horneffer-van der Sluis V; Lewis M; Sebastian S; Lees CW; Teare JP; Hart A; Goodhand JR; Kennedy NA; Korcsmaros T; Marchesi JR; Ahmad T; Powell N
    EBioMedicine; 2023 Feb; 88():104430. PubMed ID: 36634565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 vaccination safety and associated health care utilization among adults with inflammatory bowel disease - a population-based self-controlled case series analysis.
    Lee JJY; Bernatsky S; Benchimol EI; Kuenzig ME; Kwong JC; Li Q; Widdifield J
    BMC Gastroenterol; 2024 May; 24(1):189. PubMed ID: 38816836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of Covid-19 vaccination acceptance in IBD patients: a prospective study.
    Viola A; Muscianisi M; Voti RL; Costantino G; Alibrandi A; Fries W
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e1042-e1045. PubMed ID: 35048662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination in inflammatory bowel disease patients: attitudes, knowledge, and uptake.
    Malhi G; Rumman A; Thanabalan R; Croitoru K; Silverberg MS; Hillary Steinhart A; Nguyen GC
    J Crohns Colitis; 2015 Jun; 9(6):439-44. PubMed ID: 25908717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary Care Professionals' Attitudes Towards Vaccination Recommendation for Patients With Inflammatory Bowel Disease.
    Xu F; deJong N; Kappelman MD; Greenlund KJ; Carlson SA
    Inflamm Bowel Dis; 2023 May; 29(5):726-734. PubMed ID: 35779060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 Vaccine Is Effective in Inflammatory Bowel Disease Patients and Is Not Associated With Disease Exacerbation.
    Lev-Tzion R; Focht G; Lujan R; Mendelovici A; Friss C; Greenfeld S; Kariv R; Ben-Tov A; Matz E; Nevo D; Barak-Corren Y; Dotan I; Turner D
    Clin Gastroenterol Hepatol; 2022 Jun; 20(6):e1263-e1282. PubMed ID: 34954338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ensuring High and Equitable COVID-19 Vaccine Uptake Among Patients With IBD.
    Caldera F; Balzora S; Hayney MS; Farraye FA; Cross RK
    Inflamm Bowel Dis; 2021 Oct; 27(10):1703-1705. PubMed ID: 34013958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic.
    Lin S; Lau LH; Chanchlani N; Kennedy NA; Ng SC
    Gut; 2022 Jul; 71(7):1426-1439. PubMed ID: 35477864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.